Tag: Geriatric mental health

According to the FDA, in May 2023, brexpiprazole (Rexulti) became the first and only medication specifically approved to treat agitation associated with dementia due to Alzheimer's disease. Choosing **what medication is used for senile agitation** is complex, requiring careful consideration of risks and the significant benefits of non-pharmacological interventions.

Behavioral and psychological symptoms of dementia, including aggression and agitation, affect up to 90% of people living with the condition. When managing these challenging behaviors, understanding what medication is used to calm aggressive dementia patients is crucial, but non-drug interventions are considered the first-line approach.